StockData
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

CARLSMED, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.66+0.25 (+1.86%)

Close on Oct 19, 2026

Market cap
$371.43M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 5, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 5, 2026After market close$18.90M$-0.39–
Q1 FY2026
Ended Mar 31, 2026
May 5, 2026After market close$16.10M$-0.32–
Q4 FY2025
Ended Dec 31, 2025
Feb 25, 2026After market close$15.20M$-0.32–
Q3 FY2025
Ended Sep 30, 2025
Nov 6, 2025After market close$13.10M$-0.40–
Q2 FY2025
Ended Jun 30, 2025
Aug 28, 2025After market close$12.10M$-1.47–

Company guidance

Outlook given with results on Aug 5, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Revenuefull year 2026$74.00M to $78.00MRaised

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Carlsmed filed with the SEC